Soleus Capital Management, L.P.
Position in ORGO — Organogenesis Holdings Inc.
CIK 1802630
GREENWICH, CT
Position in ORGO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$24,642,510
+$738,807 QoQ
Shares Held
10,140,951
+0.5% QoQ
Ownership
7.88%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#2
of 134 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $361,941,334 across 8 Drug Manufacturers - Specialty & Generic names. ORGO ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
225,587 | $122,229,804 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
867,760 | $71,833,172 | |
| 3 | ALKS |
Alkermes plc.
|
1,029,252 | $53,932,804 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,064,000 | $43,655,920 | |
| 5 | ORGO |
Organogenesis Holdings Inc.
This page
|
10,140,951 | $24,642,510 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
520,000 | $24,185,200 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
246,353 | $15,754,274 | |
| 8 | EOLS |
Evolus, Inc.
|
822,428 | $5,707,650 |
All Filings in ORGO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,642,510 | 10,140,951 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $23,903,703 | 10,085,951 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $51,727,226 | 9,985,951 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $51,195,769 | 12,131,699 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,176,664 | 12,343,351 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $53,906,476 | 12,478,351 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $39,951,603 | 12,484,876 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,862,045 | 11,839,876 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,253,071 | 11,518,954 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,187,882 | 9,573,198 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $36,658,670 | 8,963,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,101,798 | 12,296,163 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,937,169 | 11,728,063 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,987,024 | 9,853,063 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,806,639 | 7,363,063 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,024,564 | 6,489,063 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,796,494 | 5,286,167 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,356,072 | 2,540,167 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,471,563 | 1,999,087 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,111,990 | 639,887 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||